Hyperinsulinemia due to altered insulin secretion contributes to insulin resistance in chronic intermittent hypoxia independently of obesity Source: International Congress 2019 – Insights into the pathophysiology of sleep-disordered breathing Year: 2019
Impaired glucose tolerance in COPD patients with hypoxaemia Source: Eur Respir J 2001; 18: Suppl. 33, 211s Year: 2001
Inadequate glucose control in type 2 diabetes is associated with impaired lung function and with systemic inflammation Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care Year: 2009
Systemic inflammation is enhanced by acute hyperglycaemia and suppressed by insulin in COPD Source: Annual Congress 2011 - Airways disease comorbidities and general aspects Year: 2011
Decreased pulmonary function tests are affected by blood glucose tolerance Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020
A potential role for insulin resistance in experimental pulmonary hypertension Source: Eur Respir J 2013; 41: 861-871 Year: 2013
The effects and mechanisms of chronic intermittent hypoxia on insulin resistance and glucose tolerance in non-obese rats Source: Annual Congress 2013 –Of mice and men: sleep disordered breathing Year: 2013
Evaluation of association between COPD and metabolic syndrome, and insulin resistance Source: Annual Congress 2012 - COPD comorbidities II Year: 2012
Metabolic syndrome, fasting glucose and arterial stiffness in patients with COPD: The CIROCO study Source: Annual Congress 2010 - Pulmonary rehabilitation and chronic care: new developments in interventions, assessment and care Year: 2010
Impaired glucose homeostasis in children with acute exacerbation of asthma is transitory Source: Eur Respir J 2001; 18: Suppl. 33, 42s Year: 2001
Glucose tolerance, beta-cell function and insulin sensitivity in cystic fibrosis patients awaiting lung transplantation Source: Eur Respir J 2006; 28: Suppl. 50, 780s Year: 2006
Leptin, visfatin, insulin resistance, body composition change in chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: phenotyping and monitoring Year: 2010
Endothelin-1 polymorphism involved in the impaired exercise tolerance in COPD patients: A precursor of pulmonary hypertension? Source: Annual Congress 2010 - Gas exchange and paediatric exercise testing Year: 2010
Type 2 diabetes-related “pulmonary insulin resistance” as a novel mechanism that complicates COPD phenotypes in mice Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017
Leptin in relation to systemic inflammation and regulation of the energy balance Source: ISSN=1025-448x, ISBN=1-904097-27-8, page=56 Year: 2003
Reduced lung function is an independent risk factor for the development of impaired glucose tolerance? Source: Annual Congress 2011 - Comorbidities and impact on society of asthma and COPD Year: 2011
Glucose tolerance and mobilization of neutrophils in smokers with and without chronic obstructive pulmonary disease. Source: International Congress 2019 – Comorbidities in COPD and asthma: body composition and diabetes Year: 2019
Clinical parameters and biomarkers for the early detection of impaired glucose tolerance in OSA patients Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012
Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome Source: Eur Respir J 2003; 22: 156-160 Year: 2003
Systemic inflammation and exercise tolerance in COPD Source: Annual Congress 2013 –Mechanisms contributing to exercise limitation in health and respiratory, cardiac and pulmonary vascular diseases Year: 2013